Crepaldi T - Search Results

1

Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing.

Galluzzo A, Gallo S, Pardini B, Birolo G, Fariselli P, Boretto P, Vitacolonna A, Peraldo-Neia C, Spilinga M, Volpe A, Celentani D, Pidello S, Bonzano A, Matullo G, Giustetto C, Bergerone S, Crepaldi T. Galluzzo A, et al. Among authors: crepaldi t. ESC Heart Fail. 2021 Aug;8(4):2907-2919. doi: 10.1002/ehf2.13371. Epub 2021 May 2. ESC Heart Fail. 2021. PMID: 33934544 Free PMC article.

2

Signaling to cardiac hypertrophy: insights from human and mouse RASopathies.

Sala V, Gallo S, Leo C, Gatti S, Gelb BD, Crepaldi T. Sala V, et al. Among authors: crepaldi t. Mol Med. 2012 Sep 7;18(1):938-47. doi: 10.2119/molmed.2011.00512. Mol Med. 2012. PMID: 22576369 Free PMC article. Review.

3

Gene expression profiling of HGF/Met activation in neonatal mouse heart.

Gatti S, Leo C, Gallo S, Sala V, Bucci E, Natale M, Cantarella D, Medico E, Crepaldi T. Gatti S, et al. Among authors: crepaldi t. Transgenic Res. 2013 Jun;22(3):579-93. doi: 10.1007/s11248-012-9667-2. Epub 2012 Dec 6. Transgenic Res. 2013. PMID: 23224784

4

MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Sala V, Bergerone S, Gatti S, Gallo S, Ponzetto A, Ponzetto C, Crepaldi T. Sala V, et al. Among authors: crepaldi t. Cell Mol Life Sci. 2014 Apr;71(8):1439-52. doi: 10.1007/s00018-013-1504-0. Epub 2013 Nov 12. Cell Mol Life Sci. 2014. PMID: 24218009 Review.

5

Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy.

Gallo S, Gatti S, Sala V, Albano R, Costelli P, Casanova E, Comoglio PM, Crepaldi T. Gallo S, et al. Among authors: crepaldi t. Cell Death Dis. 2014 Apr 17;5(4):e1185. doi: 10.1038/cddis.2014.155. Cell Death Dis. 2014. PMID: 24743740 Free PMC article.

6

Cellular and molecular mechanisms of HGF/Met in the cardiovascular system.

Gallo S, Sala V, Gatti S, Crepaldi T. Gallo S, et al. Among authors: crepaldi t. Clin Sci (Lond). 2015 Dec;129(12):1173-93. doi: 10.1042/CS20150502. Clin Sci (Lond). 2015. PMID: 26561593 Review.

7

Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib.

Sala V, Gallo S, Gatti S, Medico E, Vigna E, Cantarella D, Fontani L, Natale M, Cimino J, Morello M, Comoglio PM, Ponzetto A, Crepaldi T. Sala V, et al. Among authors: crepaldi t. J Mol Cell Cardiol. 2016 Apr;93:84-97. doi: 10.1016/j.yjmcc.2016.02.017. Epub 2016 Feb 26. J Mol Cell Cardiol. 2016. PMID: 26924269

8

A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart.

Sala V, Gatti S, Gallo S, Medico E, Cantarella D, Cimino J, Ponzetto A, Crepaldi T. Sala V, et al. Among authors: crepaldi t. Biomed Res Int. 2016;2016:9549036. doi: 10.1155/2016/9549036. Epub 2016 May 19. Biomed Res Int. 2016. PMID: 27298830 Free PMC article.

9

Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes.

Sala V, Gallo S, Gatti S, Vigna E, Ponzetto A, Crepaldi T. Sala V, et al. Among authors: crepaldi t. Biomedicines. 2015 Feb 12;3(1):124-137. doi: 10.3390/biomedicines3010124. Biomedicines. 2015. PMID: 28536403 Free PMC article.

10

HGF/Met Axis in Heart Function and Cardioprotection.

Gallo S, Sala V, Gatti S, Crepaldi T. Gallo S, et al. Among authors: crepaldi t. Biomedicines. 2014 Oct 21;2(4):247-262. doi: 10.3390/biomedicines2040247. Biomedicines. 2014. PMID: 28548070 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page